Prestige Consumer Healthcare Inc. Stock
Our community is currently high on Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 107 € shows a very positive potential of 60.9% compared to the current price of 66.5 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | - | 1.527% | 3.101% | 19.820% | 19.820% | 83.702% | 157.403% |
| Apollo Medical Holdings, Inc. | - | 1.765% | -9.896% | 8.805% | -3.352% | - | - |
| Petmed Express Inc | -0.270% | -0.053% | -14.149% | -71.690% | -44.588% | -84.589% | - |
| Ingles Markets Inc | -2.210% | -0.746% | -3.623% | -20.359% | -13.636% | 27.885% | - |
Comments
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat